N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  MedChemComm

• Publication date

  2018-06-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c8md00068aPMID 30108985PMCID PMC6071728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.

  2017cited by this paper
• Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K).

  2017cited by this paper
• 4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade.

  2017cited by this paper
• The non-canonical NF-κB pathway in immunity and inflammation

  2017cited by this paper
• NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer

  2016cited by this paper
• Refining the chemical toolbox to be fit for educational and practical purpose for drug discovery in the 21st Century.

  2015cited by this paper
• Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer

  2015cited by this paper
• Computational design and discovery of nanomolar inhibitors of IκB kinase β.

  2015cited by this paper
• Targeting the NFκB signaling pathways for breast cancer prevention and therapy.

  2014cited by this paper
• Synthesis, antibacterial activity and cytotoxicity of new fused pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c][1,2,4]triazine derivatives from new 5-aminopyrazoles.

  2013cited by this paper
• Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures.

  2013cited by this paper
• The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site.

  2012cited by this paper
• Synthesis of novel 3,4-diaryl-5-aminopyrazoles as potential kinase inhibitors

  2011cited by this paper
• Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation.

  2011cited by this paper
• Non-canonical NF-κB signaling pathway

  2011cited by this paper
• Constitutive activation of nuclear factor‐κB is preferentially involved in the proliferation of basal‐like subtype breast cancer cell lines

  2009cited by this paper
• Her2 Activates NF-κB and Induces Invasion Through the Canonical Pathway Involving IKKα

  2009cited by this paper
• Recent Developments in Aminopyrazole Chemistry

  2009cited by this paper
• The synthesis, structure and properties of N-acetylated derivatives of ethyl 3-amino-1H-pyrazole-4-carboxylate.

  2007cited by this paper
• Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

  2007cited by this paper
• Synthesis of a new series of ditopic proligands for metal salts: differing regiochemistry of electrophilic attack at 3{5}-amino-5{3}-(pyrid-2-yl)-1H-pyrazole

  2006cited by this paper
• Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.

  2004cited by this paper
• Novel IKK inhibitors: β-carbolines

  2003cited by this paper
• Novel IKK inhibitors: beta-carbolines.

  2003cited by this paper
• NF-kappa B as a therapeutic target in multiple myeloma.

  2002cited by this paper
• NF-κB as a Therapeutic Target in Multiple Myeloma*

  2002cited by this paper
• NMR study of the solid‐state rearrangement of 3‐amino‐1‐ and ‐2‐(chloroacetyl)pyrazole to 3‐(chloroacetamido)pyrazole

  1994cited by this paper
• Studies of the synthesis of heterocyclic compounds. Part VII. The preparation of some new 3- and 5-amino-pyrazoles by endocyclic N-substitution of 3(5)-aminopyrazoles

  1982cited by this paper

• P-glycoprotein-independent cytotoxic effects of 5-aminopyrazole in L1210 leukemia cells

  2025cites this paper
• Pharmacophore Modeling of Janus Kinase Inhibitors: Tools for Drug Discovery and Exposition Prediction

  2025cites this paper
• UNLOCKING THE THERAPEUTIC POTENTIAL: EXPLORING NF-κB AS A VIABLE TARGET FOR DIVERSE PHARMACOLOGICAL APPROACHES

  2024cites this paper
• Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives

  2024cites this paper
• Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology.

  2024cites this paper
• NIK Is a Mediator of Inflammation and Intimal Hyperplasia in Endothelial Denudation-Induced Vascular Injury

  2024cites this paper
• Transcriptional induction of NF-κB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells

  2023cites this paper
• Analysis of the binding pattern of NIK inhibitors by computational simulation

  2023cites this paper
• Transcriptional Induction of NF-kB-Inducing Kinase by E2F4/5 Facilitates Collective Invasion of Glioma Cells

  2023cites this paper
• Amino-Pyrazoles in Medicinal Chemistry: A Review

  2023influential citation
• Aberrant accumulation of NIK promotes tumor growth by dysregulating translation and post-translational modifications in breast cancer

  2023cites this paper
• The Therapeutic Potential of Targeting NIK in B Cell Malignancies

  2022cites this paper
• Discovery of pyrazole derivatives as potent inhibitor of NF-ĸB for possible benefit in abdominal aortic aneurysms

  2021cites this paper
• Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety

  2021cites this paper
• Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals.

  2021cites this paper
• Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases.

  2021cites this paper
• Hydroxyazoles as acid isosteres and their drug design applications—Part 1: Monocyclic systems

  2021cites this paper
• Aberrant accumulation of NIK promotes tumorigenicity by dysregulating post-translational modifications in breast cancer

  2021cites this paper
• Hydroxyazoles as acid isosteres and their drug design applications—Part 2: Bicyclic systems

  2021cites this paper
• A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats

  2021cites this paper
• Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2

  2020cites this paper
• Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond

  2020cites this paper
• Discovery of a potent and selective NF-κB-inducing kinase (NIK) inhibitor that has anti-inflammatory effects in vitro and in vivo.

  2020cites this paper
• Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer

  2020cites this paper
• NIK as a Druggable Mediator of Tissue Injury.

  2019cites this paper
• Design and optimize N‐substituted EF24 as effective and low toxicity NF‐κB inhibitor for lung cancer therapy via apoptosis‐to‐pyroptosis switch

  2019cites this paper
• Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies.

  2019cites this paper
• Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.

  2019cites this paper
• Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I1/2 NIK Inhibitors

  2019cites this paper
• Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.

  2019cites this paper
• 4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding site.

  2018cites this paper